Detalhe da pesquisa
1.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Ann Hematol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438627
2.
Dual-Activity Fluoroquinolone-Transportan 10 Conjugates Offer Alternative Leukemia Therapy during Hematopoietic Cell Transplantation.
Mol Pharmacol
; 105(1): 39-53, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977824
3.
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Am J Hematol
; 97(8): 1023-1034, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617104
4.
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors.
Immun Ageing
; 19(1): 51, 2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324179
5.
Late polycythemic transformation in JAK2-mutated essential thrombocythemia patients-characteristics along with a validation of 2016 WHO criteria.
Eur J Haematol
; 103(6): 558-563, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31449697
6.
Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation.
Ann Hematol
; 97(3): 509-517, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29255911
7.
Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique.
Acta Haematol
; 136(2): 123-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27410038
8.
Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q).
BMC Cancer
; 15: 508, 2015 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26152663
9.
MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT.
Arch Immunol Ther Exp (Warsz)
; 72(1)2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38847554
10.
Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort.
Hum Immunol
; 85(3): 110791, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553383
11.
Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach.
Adv Clin Exp Med
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683044
12.
The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease's phenotype.
Front Oncol
; 13: 1224590, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671053
13.
The role of daratumumab in relapsed/refractory CD38 positive acute leukemias-case report on three cases with a literature review.
Front Oncol
; 13: 1228481, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941558
14.
Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells.
Front Immunol
; 14: 1227897, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37901227
15.
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry.
Clin Lymphoma Myeloma Leuk
; 23(1): e19-e26, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396583
16.
Anagrelide in essential thrombocythemia: Efficacy and long-term consequences in young patient population.
Leuk Res
; 123: 106962, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183610
17.
Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis.
Int J Hematol
; 116(3): 442-445, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429330
18.
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs.
Blood Adv
; 6(17): 5171-5183, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802458
19.
Immune Status Against Hepatitis B in Patients After Allogeneic Hematopoietic Cell Transplantation-Factors Affecting Early and Long-Lasting Maintenance of Protective Anti-HBs Titers.
Front Immunol
; 11: 586523, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335530
20.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Lancet Haematol
; 7(1): e28-e39, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606445